查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1658704

VNA（供應商中立檔案）和PACS全球市場趨勢、分析、競爭格局和預測（2019-2031年），按類型、組件、部署模式、應用、最終用戶和地區分類

Vendor Neutral Archive and PACS Market, By Type; By Component; By Deployment Mode; By Application; By End User; By Region, Global Trend Analysis, Competitive Landscape & Forecast, 2019-2031
出版日期: | 出版商: Blueweave Consulting | 英文 525 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球 VNA（供應商中立檔案）和 PACS 市場規模預計將從2024年的43億美元成長到2031年的63億美元，預測期內的年複合成長率為 5.90%。

影像設備的進步、醫療保健投資的增加以及由於慢性病的流行而導致的醫療程序數量的增加是該市場的主要成長要素。此外，在預測期內，雲端儲存和主導分析等技術的日益普及也有望推動市場的發展。

商業機會：對數位健康和醫療圖像的需求不斷增加

遠端保健等數位醫療技術的日益普及以及對醫療圖像的需求不斷成長是全球 NVA 和 PACS 市場的主要成長動力。隨著醫療保健產業日益數位化，高效儲存、搜尋和共用醫學影像和病患資料的需求激增。影像技術（MRI、 電腦斷層掃描、數位X光等）的進步日益增加必須管理的病患資料量。 VNA 允許醫療保健提供者以與供應商無關的格式儲存資料，確保系統之間的長期可存取性和互通性。

主導全球 VNA 和 PACS 市場的VNA 細分市場：

VNA 部門佔有最大佔有率。根據美國國家生物技術資訊中心的一篇論文，使用 VNA 可以在容量基礎上降低 30%以上的儲存成本，並將服務和維護成本降低 10%至 15%。 VNA 可以集中記錄患者影像，提高醫療機構的整體護理品質並有助於推動市場擴張。

北美佔很大佔有率：

全球 VNA 和 PACS 市場由北美主導。該地區雲端儲存的使用日益增多以及醫學影像資料量的不斷增加推動了對完整系統的需求，例如 VNA/PACS 系統，該系統可以儲存、管理並提供標準化格式和介面的醫學影像的即時存取。然而，預計預測期內亞太地區將以更快的速度擴張。該區域市場的擴張主要受到醫療保健體系的興起所推動，尤其是在韓國、越南和印度等新興市場。

本報告調查了全球 VNA（供應商中立檔案）和 PACS 市場，並提供了市場概況摘要、影響市場成長的各種因素分析、技術趨勢、法律制度、市場規模趨勢和預測、各區分、地區/主要國家的明細、競爭環境以及主要企業的概況。

目錄

第1章 調查框架

第2章 執行摘要

第3章 全球VNA（供應商中立檔案）與 PACS 市場洞察

  • 產業價值鏈分析
  • DROC 分析
    • 成長動力
    • 限制因素
    • 機會
    • 課題
  • 科技進步/最新趨勢
  • 法律規範
  • 波特五力分析

第4章 全球VNA（供應商中立檔案）與 PACS 市場：行銷策略

第5章 全球VNA（供應商中立檔案）和 PACS 市場：定價分析

第6章 全球VNA（供應商中立檔案）和 PACS 市場：區域分析

  • 區域分析
  • 市場吸引力分析

第7章 全球VNA（供應商中立檔案）和 PACS 市場概覽

  • 市場規模及預測
  • 市場佔有率和預測
    • 依類型
      • 供應商中立檔案（VNA）
      • 影像存檔與通訊系統（PACS）
    • 依組件
      • 軟體
      • 硬體
      • 服務
    • 依部署方式
      • 雲端
      • 本地
      • 混合
    • 依應用
      • 放射科
      • 心臟病
      • 腫瘤
      • 整形外科
      • 其他
    • 依最終用戶
      • 醫院
      • 診斷中心
      • 研究所
      • 其他
    • 依地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東和非洲

第8章 北美 VNA（供應商中立檔案）和 PACS 市場

  • 市場規模及預測
  • 市場佔有率和預測
  • 美國
  • 加拿大

第9章 歐洲 VNA（供應商中立檔案）與 PACS 市場

  • 市場規模及預測
  • 市場佔有率和預測
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 比利時
  • 俄羅斯
  • 荷蘭
  • 其他

第10章 亞太地區 VNA（供應商中立檔案）與 PACS 市場

  • 市場規模及預測
  • 市場佔有率和預測
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲和紐西蘭
  • 印尼
  • 馬來西亞
  • 新加坡
  • 越南
  • 其他

第11章 拉丁美洲 VNA（供應商中立檔案）與 PACS 市場

  • 市場規模及預測
  • 市場佔有率和預測
  • 巴西
  • 墨西哥
  • 阿根廷
  • 秘魯
  • 其他

第12章 中東和非洲 VNA（供應商中立檔案）和 PACS 市場

  • 市場規模及預測
  • 市場佔有率和預測
  • 沙烏地阿拉伯
  • UAE
  • 卡達
  • 科威特
  • 南非
  • 奈及利亞
  • 阿爾及利亞
  • 其他

第13章 競爭格局

  • 主要企業及其產品列表
  • 企業市場占有率分析
  • 競爭性基準化分析：根據業務參數
  • 重大策略發展（併購和聯盟）

第14章 地緣政治緊張局勢加劇對全球 VNA（供應商中立檔案）和 PACS 市場的影響

第15章 公司簡介（公司概況、財務矩陣、競爭格局、關鍵人員、主要競爭對手、聯繫、策略展望、SWOT 分析）

  • Agfa Healthcare
  • Dell Technologies
  • Fujifilm
  • GE Healthcare
  • IBM
  • Koninklijke Philips
  • Lexmark
  • McKesson
  • Novarad
  • Siemens Healthineers
  • Merge Healthcare
  • Nuance Communications
  • 其他主要企業

第16章 主要策略建議

第17章 調查方法

簡介目錄
Product Code: BWC25064

Global Vendor Neutral Archive (VNA) and PACS Market to Reach USD 6.3 Billion by 2031

Global Vendor Neutral Archive (VNA) and PACS Market is flourishing because of the growing adoption of digital imaging and electronic health records (EHR) in healthcare facilities and a spurring demand for cloud-based VNA solutions.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Vendor Neutral Archive (VNA) and PACS Market size at USD 4.3 billion in 2024. During the forecast period between 2025 and 2031, BlueWeave expects Global Vendor Neutral Archive (VNA) and PACS Market size to expand at a CAGR of 5.90% reaching a value of USD 6.3 billion by 2031. Advances in imaging equipment, rising healthcare investment, and the rise in medical procedures due to the prevalence of chronic diseases are major growth factors for Global Vendor Neutral Archive (VNA) and PACS Market. Additionally, the growing adoption of technologies, such as cloud storage and AI-driven analytics, is expected to drive the market over the forecast period.

Opportunity - Increasing Demand for Digital Health and Medical Imaging

The rising adoption of digital health technologies, such as telehealth, and growing demand for medical imaging are emerging as key growth drivers for Global Vendor Neutral Archive (VNA) and PACS Market. With the rising adoption of digitization in the healthcare industry, the need for efficient storage, retrieval, and sharing of medical images and patient data has spiked. The advancements in imaging technologies (like MRI, CT scans, and digital X-rays) have resulted in a rise in the volume of patient data that needs to be managed. VNAs enable healthcare providers to store data in a vendor-neutral format, ensuring long-term accessibility and interoperability across systems.

Impact of Escalating Geopolitical Tensions on Global Vendor Neutral Archive (VNA) and PACS Market

Intensifying geopolitical tensions posed many challenges for Global Vendor Neutral Archive (VNA) and PACS Market. The manufacturing and distribution processes of VNA and PACS systems are hampered by geopolitical instability causing disruptions in the global supply chain. Sanctions or tariffs, for example, prevent the free movement of vital software or components related to VNA and PACS. The adoption or deployment of VNA/PACS systems across the healthcare industry may be slowed down by delays experienced by businesses operating in affected areas, which might raise production and delivery costs. The rise in cyberattacks that target essential infrastructure, particularly healthcare systems, is another significant issue linked to geopolitical tensions on Global Vendor Neutral Archive (VNA) and PACS Market.

VNA Segment Dominates Global VNA and PACS Market

The vendor neutral archive (VNA) segment holds the largest share of Global Vendor Neutral Archive (VNA) and PACS Market. A National Center for Biotechnology Information paper claims that the use of vendor-neutral archives (VNA) reduces storage unit costs by over 30% in terms of volume and service and maintenance costs by 10%-15%. VNAs offer centralized patient-imaging records, which enhances the general quality of care in healthcare facilities and propels the market's expansion.

North America Holds Major Share in Global VNA and PACS Market

North America dominates Global Vendor Neutral Archive (VNA) and PACS Market. The region's growing use of cloud storage and the volume of medical imaging data drive the need for a complete system, such VNA/PACS systems, to store, manage, and offer real-time access to medical images in a standardized format and interface. However, over the forecast period, the APAC area is anticipated to expand at a rapid pace. The regional market's expansion is mostly due to the thriving healthcare system, especially in developing nations like South Korea, Vietnam, and India.

Competitive Landscape

Major companies in Global Vendor Neutral Archive (VNA) and PACS Market include Agfa Healthcare, Dell Technologies, Fujifilm, GE Healthcare, IBM, Koninklijke Philips, Lexmark, McKesson, Novarad, Siemens Healthineers, Merge Healthcare, and Nuance Communications. The presence of high number of companies intensify the market competition as they compete to gain a significant market share. These companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches to further enhance their market share.

The in-depth analysis of the report provides information about growth potential and upcoming trends in Global Vendor Neutral Archive (VNA) and PACS Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Vendor Neutral Archive (VNA) and PACS Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Vendor Neutral Archive (VNA) and PACS Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Adoption of Digital Imaging and Electronic Health Records (EHR) in Healthcare Facilities
      • 3.2.1.2. Growth in the Demand for Cloud-Based VNA Solutions
      • 3.2.1.3. Rising Need for Interoperability and Consolidation of Medical Imaging Data
    • 3.2.2. Restraints
      • 3.2.2.1. High Initial Investment and Implementation Costs
      • 3.2.2.2. Data Security and Privacy Concerns in Storing Medical Imaging Data
      • 3.2.2.3. Complexity in Integrating VNA with Legacy Healthcare Systems
    • 3.2.3. Opportunities
      • 3.2.3.1. Expansion of Healthcare Services in Emerging Markets
      • 3.2.3.2. Increasing Demand for Scalable, Flexible Storage Solutions
    • 3.2.4. Challenges
      • 3.2.4.1. Ensuring Data Integrity and Seamless Access to Historical Imaging Data
      • 3.2.4.2. Competition from Traditional PACS Solutions and Proprietary Storage Systems
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Vendor Neutral Archive (VNA) and PACS Market: Marketing Strategies

5. Global Vendor Neutral Archive (VNA) and PACS Market: Pricing Analysis

6. Global Vendor Neutral Archive (VNA) and PACS Market: Geographical Analysis

  • 6.1. Global Vendor Neutral Archive (VNA) and PACS Market, Geographical Analysis, 2024
  • 6.2. Global Vendor Neutral Archive (VNA) and PACS Market, Market Attractiveness Analysis, 2024-2031

7. Global Vendor Neutral Archive (VNA) and PACS Market Overview

  • 7.1. Market Size & Forecast, 2019-2031
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
      • 7.2.1.1. Vendor Neutral Archive (VNA)
      • 7.2.1.2. Picture Archiving and Communication System (PACS)
    • 7.2.2. By Component
      • 7.2.2.1. Software
      • 7.2.2.2. Hardware
      • 7.2.2.3. Services
    • 7.2.3. By Deployment Mode
      • 7.2.3.1. Cloud
      • 7.2.3.2. On-premises
      • 7.2.3.3. Hybrid
    • 7.2.4. By Application
      • 7.2.4.1. Radiology
      • 7.2.4.2. Cardiology
      • 7.2.4.3. Oncology
      • 7.2.4.4. Orthopedics
      • 7.2.4.5. Others
    • 7.2.5. By End User
      • 7.2.5.1. Hospitals
      • 7.2.5.2. Diagnostic Centers
      • 7.2.5.3. Research Institutes
      • 7.2.5.4. Others
    • 7.2.6. By Region
      • 7.2.6.1. North America
      • 7.2.6.2. Europe
      • 7.2.6.3. Asia Pacific (APAC)
      • 7.2.6.4. Latin America (LATAM)
      • 7.2.6.5. Middle East and Africa (MEA)

8. North America Vendor Neutral Archive (VNA) and PACS Market

  • 8.1. Market Size & Forecast, 2019-2031
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Component
    • 8.2.3. By Deployment Mode
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
      • 8.2.6.1. United States
      • 8.2.6.1.1. By Type
      • 8.2.6.1.2. By Component
      • 8.2.6.1.3. By Deployment Mode
      • 8.2.6.1.4. By Application
      • 8.2.6.1.5. By End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. By Type
      • 8.2.6.2.2. By Component
      • 8.2.6.2.3. By Deployment Mode
      • 8.2.6.2.4. By Application
      • 8.2.6.2.5. By End User

9. Europe Vendor Neutral Archive (VNA) and PACS Market

  • 9.1. Market Size & Forecast, 2019-2031
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Component
    • 9.2.3. By Deployment Mode
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
      • 9.2.6.1. Germany
      • 9.2.6.1.1. By Type
      • 9.2.6.1.2. By Component
      • 9.2.6.1.3. By Deployment Mode
      • 9.2.6.1.4. By Application
      • 9.2.6.1.5. By End User
      • 9.2.6.2. United Kingdom
      • 9.2.6.2.1. By Type
      • 9.2.6.2.2. By Component
      • 9.2.6.2.3. By Deployment Mode
      • 9.2.6.2.4. By Application
      • 9.2.6.2.5. By End User
      • 9.2.6.3. Italy
      • 9.2.6.3.1. By Type
      • 9.2.6.3.2. By Component
      • 9.2.6.3.3. By Deployment Mode
      • 9.2.6.3.4. By Application
      • 9.2.6.3.5. By End User
      • 9.2.6.4. France
      • 9.2.6.4.1. By Type
      • 9.2.6.4.2. By Component
      • 9.2.6.4.3. By Deployment Mode
      • 9.2.6.4.4. By Application
      • 9.2.6.4.5. By End User
      • 9.2.6.5. Spain
      • 9.2.6.5.1. By Type
      • 9.2.6.5.2. By Component
      • 9.2.6.5.3. By Deployment Mode
      • 9.2.6.5.4. By Application
      • 9.2.6.5.5. By End User
      • 9.2.6.6. Belgium
      • 9.2.6.6.1. By Type
      • 9.2.6.6.2. By Component
      • 9.2.6.6.3. By Deployment Mode
      • 9.2.6.6.4. By Application
      • 9.2.6.6.5. By End User
      • 9.2.6.7. Russia
      • 9.2.6.7.1. By Type
      • 9.2.6.7.2. By Component
      • 9.2.6.7.3. By Deployment Mode
      • 9.2.6.7.4. By Application
      • 9.2.6.7.5. By End User
      • 9.2.6.8. The Netherlands
      • 9.2.6.8.1. By Type
      • 9.2.6.8.2. By Component
      • 9.2.6.8.3. By Deployment Mode
      • 9.2.6.8.4. By Application
      • 9.2.6.8.5. By End User
      • 9.2.6.9. Rest of Europe
      • 9.2.6.9.1. By Type
      • 9.2.6.9.2. By Component
      • 9.2.6.9.3. By Deployment Mode
      • 9.2.6.9.4. By Application
      • 9.2.6.9.5. By End User

10. Asia Pacific Vendor Neutral Archive (VNA) and PACS Market

  • 10.1. Market Size & Forecast, 2019-2031
    • 10.1.1. By Value (USD Billion)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Component
    • 10.2.3. By Deployment Mode
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
      • 10.2.6.1. China
      • 10.2.6.1.1. By Type
      • 10.2.6.1.2. By Component
      • 10.2.6.1.3. By Deployment Mode
      • 10.2.6.1.4. By Application
      • 10.2.6.1.5. By End User
      • 10.2.6.2. India
      • 10.2.6.2.1. By Type
      • 10.2.6.2.2. By Component
      • 10.2.6.2.3. By Deployment Mode
      • 10.2.6.2.4. By Application
      • 10.2.6.2.5. By End User
      • 10.2.6.3. Japan
      • 10.2.6.3.1. By Type
      • 10.2.6.3.2. By Component
      • 10.2.6.3.3. By Deployment Mode
      • 10.2.6.3.4. By Application
      • 10.2.6.3.5. By End User
      • 10.2.6.4. South Korea
      • 10.2.6.4.1. By Type
      • 10.2.6.4.2. By Component
      • 10.2.6.4.3. By Deployment Mode
      • 10.2.6.4.4. By Application
      • 10.2.6.4.5. By End User
      • 10.2.6.5. Australia & New Zealand
      • 10.2.6.5.1. By Type
      • 10.2.6.5.2. By Component
      • 10.2.6.5.3. By Deployment Mode
      • 10.2.6.5.4. By Application
      • 10.2.6.5.5. By End User
      • 10.2.6.6. Indonesia
      • 10.2.6.6.1. By Type
      • 10.2.6.6.2. By Component
      • 10.2.6.6.3. By Deployment Mode
      • 10.2.6.6.4. By Application
      • 10.2.6.6.5. By End User
      • 10.2.6.7. Malaysia
      • 10.2.6.7.1. By Type
      • 10.2.6.7.2. By Component
      • 10.2.6.7.3. By Deployment Mode
      • 10.2.6.7.4. By Application
      • 10.2.6.7.5. By End User
      • 10.2.6.8. Singapore
      • 10.2.6.8.1. By Type
      • 10.2.6.8.2. By Component
      • 10.2.6.8.3. By Deployment Mode
      • 10.2.6.8.4. By Application
      • 10.2.6.8.5. By End User
      • 10.2.6.9. Vietnam
      • 10.2.6.9.1. By Type
      • 10.2.6.9.2. By Component
      • 10.2.6.9.3. By Deployment Mode
      • 10.2.6.9.4. By Application
      • 10.2.6.9.5. By End User
      • 10.2.6.10. Rest of APAC
      • 10.2.6.10.1. By Type
      • 10.2.6.10.2. By Component
      • 10.2.6.10.3. By Deployment Mode
      • 10.2.6.10.4. By Application
      • 10.2.6.10.5. By End User

11. Latin America Vendor Neutral Archive (VNA) and PACS Market

  • 11.1. Market Size & Forecast, 2019-2031
    • 11.1.1. By Value (USD Billion)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Component
    • 11.2.3. By Deployment Mode
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
      • 11.2.6.1. Brazil
      • 11.2.6.1.1. By Type
      • 11.2.6.1.2. By Component
      • 11.2.6.1.3. By Deployment Mode
      • 11.2.6.1.4. By Application
      • 11.2.6.1.5. By End User
      • 11.2.6.2. Mexico
      • 11.2.6.2.1. By Type
      • 11.2.6.2.2. By Component
      • 11.2.6.2.3. By Deployment Mode
      • 11.2.6.2.4. By Application
      • 11.2.6.2.5. By End User
      • 11.2.6.3. Argentina
      • 11.2.6.3.1. By Type
      • 11.2.6.3.2. By Component
      • 11.2.6.3.3. By Deployment Mode
      • 11.2.6.3.4. By Application
      • 11.2.6.3.5. By End User
      • 11.2.6.4. Peru
      • 11.2.6.4.1. By Type
      • 11.2.6.4.2. By Component
      • 11.2.6.4.3. By Deployment Mode
      • 11.2.6.4.4. By Application
      • 11.2.6.4.5. By End User
      • 11.2.6.5. Rest of LATAM
      • 11.2.6.5.1. By Type
      • 11.2.6.5.2. By Component
      • 11.2.6.5.3. By Deployment Mode
      • 11.2.6.5.4. By Application
      • 11.2.6.5.5. By End User

12. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Market

  • 12.1. Market Size & Forecast, 2019-2031
    • 12.1.1. By Value (USD Billion)
  • 12.2. Market Share & Forecast
    • 12.2.1. By Type
    • 12.2.2. By Component
    • 12.2.3. By Deployment Mode
    • 12.2.4. By Application
    • 12.2.5. By End User
    • 12.2.6. By Country
      • 12.2.6.1. Saudi Arabia
      • 12.2.6.1.1. By Type
      • 12.2.6.1.2. By Component
      • 12.2.6.1.3. By Deployment Mode
      • 12.2.6.1.4. By Application
      • 12.2.6.1.5. By End User
      • 12.2.6.2. UAE
      • 12.2.6.2.1. By Type
      • 12.2.6.2.2. By Component
      • 12.2.6.2.3. By Deployment Mode
      • 12.2.6.2.4. By Application
      • 12.2.6.2.5. By End User
      • 12.2.6.3. Qatar
      • 12.2.6.3.1. By Type
      • 12.2.6.3.2. By Component
      • 12.2.6.3.3. By Deployment Mode
      • 12.2.6.3.4. By Application
      • 12.2.6.3.5. By End User
      • 12.2.6.4. Kuwait
      • 12.2.6.4.1. By Type
      • 12.2.6.4.2. By Component
      • 12.2.6.4.3. By Deployment Mode
      • 12.2.6.4.4. By Application
      • 12.2.6.4.5. By End User
      • 12.2.6.5. South Africa
      • 12.2.6.5.1. By Type
      • 12.2.6.5.2. By Component
      • 12.2.6.5.3. By Deployment Mode
      • 12.2.6.5.4. By Application
      • 12.2.6.5.5. By End User
      • 12.2.6.6. Nigeria
      • 12.2.6.6.1. By Type
      • 12.2.6.6.2. By Component
      • 12.2.6.6.3. By Deployment Mode
      • 12.2.6.6.4. By Application
      • 12.2.6.6.5. By End User
      • 12.2.6.7. Algeria
      • 12.2.6.7.1. By Type
      • 12.2.6.7.2. By Component
      • 12.2.6.7.3. By Deployment Mode
      • 12.2.6.7.4. By Application
      • 12.2.6.7.5. By End User
      • 12.2.6.8. Rest of MEA
      • 12.2.6.8.1. By Type
      • 12.2.6.8.2. By Component
      • 12.2.6.8.3. By Deployment Mode
      • 12.2.6.8.4. By Application
      • 12.2.6.8.5. By End User

13. Competitive Landscape

  • 13.1. List of Key Players and Their Offerings
  • 13.2. Global Vendor Neutral Archive (VNA) and PACS Company Market Share Analysis, 2024
  • 13.3. Competitive Benchmarking, By Operating Parameters
  • 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

14. Impact of Escalating Geopolitical Tensions on Global Vendor Neutral Archive (VNA) and PACS Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 15.1. Agfa Healthcare
  • 15.2. Dell Technologies
  • 15.3. Fujifilm
  • 15.4. GE Healthcare
  • 15.5. IBM
  • 15.6. Koninklijke Philips
  • 15.7. Lexmark
  • 15.8. McKesson
  • 15.9. Novarad
  • 15.10. Siemens Healthineers
  • 15.11. Merge Healthcare
  • 15.12. Nuance Communications
  • 15.13. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

  • 17.1. Qualitative Research
    • 17.1.1. Primary & Secondary Research
  • 17.2. Quantitative Research
  • 17.3. Market Breakdown & Data Triangulation
    • 17.3.1. Secondary Research
    • 17.3.2. Primary Research
  • 17.4. Breakdown of Primary Research Respondents, By Region
  • 17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable